About 4-[2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-hydroxypyridin-1-ium-2-yl]-2-phenylethyl]-1H-imidazol-5-yl]benzoic acid
4-[2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-hydroxypyridin-1-ium-2-yl]-2-phenylethyl]-1H-imidazol-5-yl]benzoic acid (PubChem CID 118859558) has the molecular formula C30H23ClN7O3+
and a molecular weight of 565.01 g/mol. Its IUPAC name is 4-[2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-hydroxypyridin-1-ium-2-yl]-2-phenylethyl]-1H-imidazol-5-yl]benzoic acid.
Molecular Properties
| Compound Name | 4-[2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-hydroxypyridin-1-ium-2-yl]-2-phenylethyl]-1H-imidazol-5-yl]benzoic acid |
| PubChem CID | 118859558 |
| Molecular Formula | C30H23ClN7O3+ |
| Molecular Weight | 565.01 g/mol |
| Exact Mass | 564.15 |
| IUPAC Name | 4-[2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-hydroxypyridin-1-ium-2-yl]-2-phenylethyl]-1H-imidazol-5-yl]benzoic acid |
| SMILES | O=C(O)c1ccc(-c2cnc(C(Cc3ccccc3)c3ccc(-c4cc(Cl)ccc4-n4cnnn4)c[n+]3O)[nH]2)cc1 |
| InChI | InChI=1S/C30H22ClN7O3/c31-23-11-13-27(37-18-33-35-36-37)24(15-23)22-10-12-28(38(41)17-22)25(14-19-4-2-1-3-5-19)29-32-16-26(34-29)20-6-8-21(9-7-20)30(39)40/h1-13,15-18,25H,14H2,(H2-,32,34,39,40,41)/p+1 |
| InChIKey | MOKZPRIHIPOAOX-UHFFFAOYSA-O |
| XLogP | 4.97 |
| TPSA | 133.69 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 565.01 |
| LogP ≤ 5 | 4.97 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'N-hydroxyl_pyridine', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Analyze 4-[2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-hydroxypyridin-1-ium-2-yl]-2-phenylethyl]-1H-imidazol-5-yl]benzoic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-hydroxypyridin-1-ium-2-yl]-2-phenylethyl]-1H-imidazol-5-yl]benzoic acid?
The IUPAC name of 4-[2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-hydroxypyridin-1-ium-2-yl]-2-phenylethyl]-1H-imidazol-5-yl]benzoic acid (CID 118859558) is 4-[2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-hydroxypyridin-1-ium-2-yl]-2-phenylethyl]-1H-imidazol-5-yl]benzoic acid.
What is the SMILES notation for 4-[2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-hydroxypyridin-1-ium-2-yl]-2-phenylethyl]-1H-imidazol-5-yl]benzoic acid?
The canonical SMILES for 4-[2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-hydroxypyridin-1-ium-2-yl]-2-phenylethyl]-1H-imidazol-5-yl]benzoic acid is O=C(O)c1ccc(-c2cnc(C(Cc3ccccc3)c3ccc(-c4cc(Cl)ccc4-n4cnnn4)c[n+]3O)[nH]2)cc1.
What is the InChIKey of 4-[2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-hydroxypyridin-1-ium-2-yl]-2-phenylethyl]-1H-imidazol-5-yl]benzoic acid?
The InChIKey is MOKZPRIHIPOAOX-UHFFFAOYSA-O. The full InChI is InChI=1S/C30H22ClN7O3/c31-23-11-13-27(37-18-33-35-36-37)24(15-23)22-10-12-28(38(41)17-22)25(14-19-4-2-1-3-5-19)29-32-16-26(34-29)20-6-8-21(9-7-20)30(39)40/h1-13,15-18,25H,14H2,(H2-,32,34,39,40,41)/p+1.
What are the key properties of 4-[2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-hydroxypyridin-1-ium-2-yl]-2-phenylethyl]-1H-imidazol-5-yl]benzoic acid?
4-[2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-hydroxypyridin-1-ium-2-yl]-2-phenylethyl]-1H-imidazol-5-yl]benzoic acid has a molecular weight of 565.01 g/mol, XLogP of 4.97, 8 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-hydroxypyridin-1-ium-2-yl]-2-phenylethyl]-1H-imidazol-5-yl]benzoic acid is sourced from PubChem (CID 118859558), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).